FdaApplication

ANDA 065012

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2000-07-03

Products (2)

ProductActive ingredientStrengthDosage form
CEFOXITINCEFOXITIN SODIUMEQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE;INJECTION
CEFOXITINCEFOXITIN SODIUMEQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE;INJECTION

2 products